Rapamycin (RPM)is produced by Streptomyces hygroscopicus FC904 isolated from soil in Fuzhou, China. It is a triene macrolide antibiotic with potential application as an immunosuppressant and drug for human gene therapy. In an attempt to improve rapamycin production, mutation and screening of the parent culture have been carried out. Thousands of survivors were obtained after mutagenesis by NTG (3mg/ml) and UV (30W, 15cm, 30 seconds) of spore suspensions. None showed improved production of RPM. Wedetermined the susceptibility to antibiotics of S. hygroscopicus FC904 by two fold dilutions of antibiotics in oatmeal agar plates. It was found that the strain was resistant to penicillin, erythromycin, RPM, tetracycline and chloramphenicol, but susceptible to mitomycin C (MIC, lO^g/ml) and aminoglycosides such as gentamicin (MIC, O.l^g/ml), kanamycin (MIC, 0.1^g/ml) and streptomycin (MIC, 0.3 /ig/ml). Protoplasts of strain FC904 were prepared after finding the best conditions for their formation. They were treated with gentamicin, erythromycin, mitomycin C and NTG. Surprisingly, gentamicin was especially effective for obtaining higher RPMproducing mutants. Mutant C14 was selected by exposing the protoplasts of the parent strain FC904 to 1 /ig/ml ofgentamicin at 28°C for 2 hours. A higher RPM-producing mutant (C14-1) was obtained from the protoplasts of mutant C14 treated with gentamicin, and its titer was 60% higher than that of the parent strain FC904 by HPLCanalysis. Another improved mutant (C14-2) was obtained from the spores of mutant C14 treated with 1 /ig/ml ofgentamicin plus 2 mg/ml ofNTG at 28°C for 2 hours. Mutant C14-2 had a titer 124% higher than FC904. The possible mechanismfor the effect of gentamicin by using protoplasts or spore suspensions will be discussed, i.e. the possibility of gentamicin being a mutagen or a selective agent.
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Fermentation
RPMproducers were incubated on 2%oatmeal agar slants at 28°C for 15 days. Three ml of20% glycerol were added to each tube, and the resulting spore suspension was 
Extraction and Bioassay
Extraction and bioassay were carried out as described in our previous paper6).
HPLC Analysis
HPLCwas performed on a column ofODS-C18 at 40°C with an eluant ofMeOH-H2O, 75 : 25 (v/v). The flow rate was 1 ml per minute, and UVabsorption of the effluent was monitored at 277 nm. The retention time for RPMwas 20.5 minutes.
Determination of MinimumInhibitory Concentration
MICs were determined by the two fold-dilution method, applying to discs which were plated oatmeal agar medium, and incubating at 28°C for 10 days.
Mutagenesis By Ultraviolet
Light , A spore suspension was diluted with sterile water and placed in an uncovered Petri dish. It was irradiated under a regeneration medium11} and incubated at 28°C for 10 days.
Treatment of Protoplasts or Spore Suspension with Antibiotics
A stock solution of antibiotic was added into a suitable measured volume of the protoplasts in P buffer or to a spore suspension in normal saline to give the correct final antibiotic concentration. After mixing completely, the mixture was incubated at 28°C for 3 hours, and then diluted to give the appropriate dilution. A 0. 1 ml of the dilution was plated onto the regeneration medium, R2YEor oatmeal agar medium (for spore dilution), and incubated at 28°C for 10-15 days. Treatment of Protoplasts with Antibiotic and/or NTG The protoplasts of S. hygroscopicus FC904 were exposed to gentamicin (GM), erythromycin (EM), mitomycin C (MC) or NTGat 28°C for 2.hours. The dosages of GM (1/ig/ml), MC (2/xg/ml) and NTG (2mg/ml) giving a killing rate of90.0% to 95.0% were adopted. In a series of choosing mutagens or selective agents for the protoplasts of the starting strain, the superiority of GMas compared to MCand NTG respectively can be seen in Table 3 . However, as expected, EMcould not be used as a selective agent in this experiment.
Results

Susceptibility of S. hygroscopicus FC904 to Antibiotics
Higher RPM-producing Mutants by Exposing the Protoplasts to GM In an attempt to obtain strains producing higher titers of RPM, mutant C14, which is among the 25 positivemutation strains shown in Table 3 , was chosen. Its titer (1 18 jUg/ml) was 36% higher than that of the starting strain FC904 (87/zg/ml) by HPLC analysis (Fig. 2) . Changes in its cultural characteristic are described in Table 4 , and depicted in Fig. 3 . A higher RPM producing mutant C14-1 was obtained from the protoplasts of mutant C14 treated with 1/ig/ml of GMat 28°C for 2 hours, and its titer (139 jUg/ml) was 60% higher than that of the starting strain FC904 by HPLC analysis (Fig. 4) .
Another Higher RPM-producing Mutant by Exposing the Spores to GMPlus NTG In the course of selecting better RPMproducing mutants, an improved C14-2 was obtained from spores (not protoplasts) of mutant C14 treated with 1 /ig/ml of GMand 2mg/ml ofNTG at 28°C for 2 hours. The titer of mutant C14-2 (195jUg/ml) increased by 124% as compared with and its second generation mutant C14-1 (B). and its third generation mutant C14-2 (B).
the starting strain (Fig. 5 ). There are very few differences between mutant C14-2 and mutant C14 in cultural characteri sti c s. bacterial growth by interfering with protein synthesis. Its action appears to interrupt the "ribosome cycle" at the initiation of protein synthesis, i.e. it causes misreading of an m-RNAcodon and a wrong amino acid is incorporated into the growing peptide chainn\ On the contrary, MCis an antitumor antibiotic which is also active against bacteria and is considered a rapidly acting selective inhibitor of DNA synthesis13). It is possible that GM is acting as a selective agent and not a mutagen.
